Published March 16, 2012 | Version v1
Journal article

Characterization of cancer stem cell properties of CD24 and CD26-positive human malignant mesothelioma cells

  • 1. Division of Clinical Immunology, Institute of Medical Science, University of Tokyo, Tokyo (Japan)
  • 2. Division of Hematology/Oncology, University of Florida Shands Cancer Center, Gainesville, FL 32610 (United States)

Description

Highlights: ► We focused on CD24 and CD26 for further analysis of CSC properties in MM. ► Their expressions were correlated with chemoresistance, cell growth, and invasion. ► Their expressions were also correlated with several cancer related genes. ► The expression of each marker was correlated with different CSC property in Meso1. ► Phosphorylation of ERK by EGF was regulated by expression of CD26, but not CD24. -- Abstract: Malignant mesothelioma (MM) is an asbestos-related malignancy characterized by rapid growth and poor prognosis. In our previous study, we have demonstrated that several cancer stem cell (CSC) markers correlated with CSC properties in MM cells. Among these markers, we focused on two: CD24, the common CSC marker, and CD26, the additional CSC marker. We further analyzed the CSC properties of CD24 and CD26-positve MM cells. We established RNAi-knockdown cells and found that these markers were significantly correlated with chemoresistance, proliferation, and invasion potentials in vitro. Interestingly, while Meso-1 cells expressed both CD24 and CD26, the presence of each of these two markers was correlated with different CSC property. In addition, downstream signaling of these markers was explored by microarray analysis, which revealed that their expressions were correlated with several cancer-related genes. Furthermore, phosphorylation of ERK by EGF stimulation was significantly affected by the expression of CD26, but not CD24. These results suggest that CD24 and CD26 differentially regulate the CSC potentials of MM and could be promising targets for CSC-oriented therapy.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2012.02.054

Additional details

Identifiers

DOI
10.1016/j.bbrc.2012.02.054;
PII
S0006-291X(12)00287-2;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
419
Journal Issue
3
Journal Page Range
p. 529-536
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45028667
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ASBESTOS; BIOLOGICAL STRESS; CELL PROLIFERATION; GENES; IN VITRO; NEOPLASMS; PHOSPHORYLATION; STEM CELLS; THERAPY
Descriptors DEC
ANIMAL CELLS; CHEMICAL REACTIONS; DISEASES; MEDICINE; SOMATIC CELLS

Optional Information

Copyright
Copyright (c) 2012 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.